GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kimia Biosciences Ltd

Kimia Biosciences appoints two independent directors; replaces company secretary

MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 04 Apr 2026, 05:08 PM IST  ·  BSE ID: af898635-3340-4cb1-be17-29044aa0dd42
View Original BSE Filing (PDF)
💡
In Simple Terms
The company appointed two new independent board directors and replaced its company secretary.
🤖 AI Summary
  • Two independent directors appointed: Avinash Prabhat and Reema Goyal, effective 4 April 2026
  • Both appointments for five-year terms, subject to shareholder approval at next AGM
  • Independent director Jagdeep Dhawan's tenure completed 28 March 2026; ceased same date
  • Company Secretary Pallavi Garg resigned 3 April 2026; Abhishek Kumar Pandey appointed replacement
  • All board committees reconstituted with new directors and authorised for Regulation 30(5)
🔢 Key Numbers — exact figures from BSE filing, not rounded
Avinash Prabhat appointment term
5 years
Reema Goyal appointment term
5 years
Jagdeep Dhawan cessation date
28 March 2026
Pallavi Garg resignation date
3 April 2026
Board meeting date
4 April 2026
🏢 How This Affects the Company
⚙️
Operational Impact
Board composition strengthened with two independent directors. Company secretary replacement ensures continuity of compliance and regulatory disclosures under Regulation 30(5).
⚠️
Risk Impact
Authorisation of Company Secretary as Key Managerial Personnel for materiality determination centralises disclosure authority. New independent directors required to undergo shareholder approval, introducing near-term approval risk.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must approve appointments of Avinash Prabhat and Reema Goyal at next AGM; voting instructions will be disclosed separately.
👤
Who Is Affected
All shareholders holding equity on record date before AGM. Approval required for both director appointments to become effective; approval deferral or rejection reverses appointments.
🔍
Management Signal
Board prioritised independent director additions and formalised Company Secretary authority under Regulation 30(5), signalling commitment to governance compliance and disclosure structure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM date and shareholder voting outcome on director appointments within 60 days
Abhishek Kumar Pandey confirmation as Company Secretary in next quarterly compliance filing
Board committee meeting minutes confirming new directors' participation and committee operations
MEDIUM RISK Director appointments contingent on shareholder approval with no approval date confirmed. Company Secretary transition introduces interim compliance continuity risk during handover period.
💡 Investor Takeaway
Board added two independent directors (five-year terms, shareholder approval pending) and replaced Company Secretary. New directors assigned to all four committees. Governance expansion confirmed; approval outcome and transition effectiveness remain trackable events.
⚖️ Strengths & Concerns

✅ Positives

  • Two independent directors appointed concurrently, addressing board diversity; includes one woman director
  • New Company Secretary explicitly authorised for Regulation 30(5) materiality determinations, clarifying disclosure authority

⚠️ Concerns

  • Shareholder approval for director appointments pending; if rejected, board structure disrupted immediately
  • Company Secretary replacement creates short-term continuity risk during transition; no overlap mentioned
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.